Michel AlChoueiry retweetledi
Beyond grateful and excited to match at Yale for IM !!!! @YaleIMed @MarkDSiegel1
Thankful for my incredible mentors, friends, and family
The dream comes true, can't wait to join an amazing team! #Match2026
English
Michel AlChoueiry
276 posts
Michel AlChoueiry
@MAlchoueiry
Postdoctoral Research Fellow at Henske Lab @BrighamWomens @Harvardmed | MD 21’ MSc. 19’ @Usjliban 🇱🇧 | #LBJ #FCB #Ferrari
Zahle,Lebanon Katılım Temmuz 2011
628 Takip Edilen539 Takipçiler
Michel AlChoueiry retweetledi
Rewatching #BreakingBad in 2025 with fresh eyes as #Radonc resident☢️
Let's talk about how Walter White's Stage IIIA lung adenocarcinoma would be treated if diagnosed today instead of 2008. 🧵 #lcsm #MedTwitter
Because honestly? The show may look very different. Here's why...
English
Michel AlChoueiry retweetledi
A dream come true. Absolutely thrilled to have matched at @MDAndersonNews for heme/onc fellowship. Grateful for my incredible support system, the mentors who shaped my path, and my training at @BCM_InternalMed.
#FellowMatch
Eric K. Singhi, MD@lungoncdoc
Thrilled to congratulate everyone on Match Day, especially the newly matched @MDAndersonNews Hematology & Medical Oncology Fellowship Class of 2029! #EndCancer
English
Michel AlChoueiry retweetledi
Thrilled to share that I’ve matched into the Cardiology Fellowship at Northwestern!
Excited to join my dream program and continue growing in the field I love. @docbfreed @NorthwesternMed @NMCardioVasc @NorthwesternU @PassmanRod @DrBradleyKnight @SusanKimMD @CCF_IMCHIEFS
English
Michel AlChoueiry retweetledi
At every major step in my career, I find myself thinking of the mentors who shaped me. Deeply grateful to @nmarrouche and Dr. Wael Jaber for their unwavering guidance, support, and belief in me. Honored to carry their mentorship with me to Northwestern. 🙏🫀
English
Michel AlChoueiry retweetledi
1/ New review on Chromophobe Renal Cell Carcinoma (ChRCC) detailing its distinct features, current management regimens, ongoing trials, and future biology-tailored treatments. @MAlchoueiry @VincentWenxinXu @LisaHenske 🧵below: doi.org/10.1016/j.crit…
English
Michel AlChoueiry retweetledi
📺In our recent interview with @MAlchoueiry, he discusses a compelling new preclinical study that positions KIT as a promising therapeutic target in metastatic chromophobe #RCC, which showed that LOP628 selectively reduced viability by roughly 60% in ChRCC-derived cell lines: guoncologynow.com/post/advancing…
English
Targeting KIT in Chromophobe RCC
GU Oncology Now@GUOncologyNow
📺In our recent interview with @MAlchoueiry, he discusses a compelling new preclinical study that positions KIT as a promising therapeutic target in metastatic chromophobe #RCC, which showed that LOP628 selectively reduced viability by roughly 60% in ChRCC-derived cell lines: guoncologynow.com/post/advancing…
English
Michel AlChoueiry retweetledi
What if your takeout could change lives?
Tomorrow, grabbing a meal from Panda Express helps fuel research and support those living with chromophobe kidney cancer.
Order here and use code 9005619 at checkout.
pandaexpress.com/?showMenu=true
#ChromophobeRCC #PandaExpress #DoGoodEatGood
English
Michel AlChoueiry retweetledi
The Henske Lab making our day with this photo! So grateful to see them sharing Chromophobe Kidney Cancer Day (Sept 5th) during their lab meeting and their planned lab lunch from Panda Express. Keep sharing and tagging us in your plans- it makes our day, and lifts the community!
English
Michel AlChoueiry retweetledi
Very excited to share our recent publication in @cgtnature 🎉
We found a targetable dependency on BCL-xL in Chromophobe renal cell carcinoma, offering new therapeutic opportunities
Check it here 👉 nature.com/articles/s4141…
@LisaHenske #kidneycancer #ChromophobeRCC x.com/kidneycoa/stat…
English
Michel AlChoueiry retweetledi
New paper on chromophobe kidney cancer discussing BCL-XL dependency in chRCC. "The BCL-xL-specific PROTAC DT2216, currently in clinical trials, may provide an opportunity for ChRCC therapy."
nature.com/articles/s4141…
#kidneycancer #chromophobeRCC #chromophobe
English
Michel AlChoueiry retweetledi
Breaking out of the group chat💥
Four years ago I was recovering from surgery and messaging my support system, the “chromophobe six”, about the lack of research, info, and community for #chRCC. There wasn’t a singled funded foundation grant for chRCC at the time.
This evening I
English
Michel AlChoueiry retweetledi
Leaders paving the way in rare #RCC 🚀 #LisaHenske unraveling chromophobe biology 🧬 & @srviswanathan driving insights into tRCC 🔬 Translating discovery to treatment & trials for patients 💪 @kidneycan #kcrs25 #KidneyCancer
English
Michel AlChoueiry retweetledi
@LisaHenske highlights some of the challenges (unfavorable immune microenvironment) and opportunities (sensitivity to ferroptosis induction) in chromophobe RCC at #KCRS25 @kidneycan @kidneycoa
English
Michel AlChoueiry retweetledi
Dr. Henske #KCRS25 providing important updates on chromophobe RCC. Interesting data regarding KIT as a potential target with early phase ongoing trials. @kidneycan
English
Michel AlChoueiry retweetledi
1/ Thrilled to share our work on Chromophobe RCC (ChRCC) and Renal Oncocytic Neoplasms (RONs) out @JCO_ASCO !!!
Incredibly thankful to my mentors @BraunMDPhD @DrChoueiri @VanAllenLab and all co-authors @DanaFarber @BIDMC_IM @Yale @BrighamWomens
Link: ascopubs.org/doi/10.1200/JC…
English
Michel AlChoueiry retweetledi
Introducing Curvia — a global mentorship platform connecting ambitious students with top-tier researchers to unlock their full potential.
💡 Get published.
🧬 Learn research from the ground up.
🌍 Build your future with dedicated mentors.
🔗 curvia.org | #ResearchMentorship #Curvia
English
Michel AlChoueiry retweetledi
Had a wonderful time presenting our work at HRS. Grateful for the opportunity! @aymanhusseinmd @CCF_IMCHIEFS @CleClinicHVTI @HRSonline
English
Presenting our work on targeting chromophobe renal cell carcinoma!
Grateful for the award and opportunity @kidneycoa @kaydaustin.
#AACR25 #SITAKIDNEY
English